phenylacetylglutamine has been researched along with Heart Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Q; Pan, R; Tao, R; Yang, Q; Zhuang, L; Zong, X | 1 |
| Awoyemi, A; Hov, JR; Trøseid, M | 1 |
| Bäckhed, F; Buffa, JA; Castel, L; Deb, A; Demuth, I; DiDonato, JA; Haghikia, A; Hazen, SL; König, M; Landmesser, U; Li, L; Li, XS; Lovano, B; Menge, CM; Mohan, ML; Naga Prasad, SV; Nemet, I; Prasad Saha, P; Romano, KA; Steinhagen-Thiessen, E; Sun, Y; Tang, WHW; Van Wagoner, DR; Witkowski, M | 1 |
| Fu, H; Huang, H; Kong, B; Shuai, W; Zhu, J | 1 |
| Chen, C; Huang, J; Li, C; Peng, L; Song, Y; Sun, Y; Wang, DW; Wang, H; Wei, H; Wu, J; Xiao, L; Zhang, Y; Zhao, C; Zhou, Z | 1 |
1 trial(s) available for phenylacetylglutamine and Heart Failure
| Article | Year |
|---|---|
Gut Microbiota-Generated Phenylacetylglutamine and Heart Failure.
Topics: Animals; Gastrointestinal Microbiome; Heart Failure; Humans; Mice; Natriuretic Peptide, Brain; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 2023 |
4 other study(ies) available for phenylacetylglutamine and Heart Failure
| Article | Year |
|---|---|
Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure.
Topics: Chronic Disease; Glutamine; Heart Failure; Humans; Kidney Diseases; Prognosis; Risk Factors | 2022 |
Phenylacetylglutamine From the Gut Microbiota: A Future Therapeutic Target in Heart Failure?
Topics: Dysbiosis; Gastrointestinal Microbiome; Glutamine; Heart Failure; Humans | 2023 |
Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Heart Failure; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases | 2023 |
Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patients.
Topics: Biomarkers; Heart Failure; Humans; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Stroke Volume | 2023 |